-
FDA Grants Orphan Drug Designation to FF-10832 for Biliary Tract Cancer
08 Jul 2025 19:48 GMT
… investigational liposomal formulation of gemcitabine—for the treatment … had progressed on gemcitabine plus cisplatin or gemcitabine-based therapy; … and non–small cell lung cancer, in a phase … & non-small cell lung cancer. ClinicalTrials.gov. Updated April …
-
A Systematic Review of SNPs Screening for Platinum-Related Pharmacodynamics and Pharmacokinetics Genes in Non-Small Cell Lung Cancer for Precision Medicine
26 Jun 2025 22:33 GMT
… cell lung cancer receiving first-line platinum-gemcitabine chemotherapy … lung cancer patients treated with platinum-based chemotherapy. Lung Cancer … -small cell lung cancer patients. Lung Cancer. 2011;72 … lung cancer: 2009 looking toward 2012. Chin J Lung Cancer …
-
Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies
08 Jul 2025 12:50 GMT
… cancer (LGSOC), non-small cell lung cancer (NSCLC), and other solid tumor … cancer (MIBC) in combination with gemcitabine and cisplatin as neoadjuvant treatment …
-
Kelun-Biotech Announces Breakthrough Therapy Designation Granted For Sacituzumab Tirumotecan (Sac-TMT) In Combination With Tagitanlimab In China For Certain Types Of Non-Small Cell Lung Cancer
11 Jun 2025 04:47 GMT
… non-squamous non-small cell lung cancer (NSCLC) without actionable … quot;
[1] Abstract #8529: Lung Cancer – Non-Small Cell Metastatic, … for marketing in a lung cancer indication. In addition, … combination with cisplatin and gemcitabine for the first-line …
-
Merck Announces MK-1084, an Investigational KRAS G12C Inhibitor, Shows Antitumor Activity in Phase 1 Trial of Patients With Advanced Colorectal Cancer and Non-Small Cell Lung Cancer Whose Tumors Harbor KRAS G12C Mutations
30 May 2025 12:21 GMT
… ) and non-small cell lung cancer (NSCLC). In patients with … test.
Non-Small Cell Lung Cancer
KEYTRUDA, in combination with … nonsquamous non-small cell lung cancer (NSCLC), with no … paclitaxel protein-bound, or gemcitabine and carboplatin) were administered …
-
Global Gemcitabine Hydrochloride Market To Reach $1.10 Billion By 2029 With A Growth Rate Of 7.0%
16 Jun 2025 12:06 GMT
… Are Driving The Gemcitabine Hydrochloride Market?
The gemcitabine hydrochloride market report … .com/report/gemcitabine-hydrochloride-global-market-report
What … Pancreatic Cancer, Non-Small Cell Lung Cancer, Bladder Cancer, Breast Cancer, …
-
Bispecific Antibody Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
07 Jul 2025 17:00 GMT
… III
Non-small cell lung cancer; Pancreatic cancer
AFM13
… I
Non Small Cell Lung Cancer
MGD024
MacroGenics
I
Hematological … for non-small cell lung cancer, metastatic colorectal cancer, … (glofitamab) in combination with gemcitabine and oxaliplatin (GemOx) to …
-
Bristol Myers Squibb Receives European Commission Approval for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Adjuvant Opdivo for Resectable, High-Risk Non-Small Cell Lung Cancer with PD-L1 Expression ≥1%
16 May 2025 11:14 GMT
… pCR and MPR.
About Lung Cancer
Lung cancer is the leading cause … combination with cisplatin and gemcitabine, is indicated as … metastatic non-small cell lung cancer, in combination with … cell lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Cost-Effectiveness Analysis of Serplulimab Combined with Nab-Paclitaxel Plus Carboplatin Compared to Nab-Paclitaxel Plus Carboplatin Alone as First-Line Treatment for Advanced Squamous Non-Small Cell Lung Cancer in China
14 Apr 2025 14:59 GMT
… diagnosed lung cancer cases and 766,898 lung cancer-related … lung cancer (NSCLC) accounts for the majority (80% - 85%) of all lung cancers … plus platinum and gemcitabine as first-line … lung cancer: a cost-effectiveness analysis. Translational Lung Cancer Res …
-
EU approves AstraZeneca's Imfinzi─in combo with chemotherapy to treat patients with resectable non─small cell lung cancer
05 Apr 2025 07:44 GMT
… Lung cancer is broadly split into NSCLC and small cell lung cancer … combination with chemotherapy (gemcitabine plus cisplatin) in … portfolio includes leading lung cancer medicines and the … improvements for people with lung cancer, including and beyond …
About
© 1995-2025